Home/Recalls/FDA-D-0510-2026
FDA DrugsClass II

Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses), Rx only, M...

Published: April 22, 2026Recall ID: D-0510-2026Category: drugsCountry: US

Reason for Recall / Hazard

Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.

Product Description & Identification

Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses), Rx only, Mfg by: Apotek inc., Toronto, Ontario, Canada, M9L 1T9, Mfg for: Apotek Corp., Weston, FL 33326, NDC 60505-0815-0

Additional Source Details

FieldValue
CityWeston
StateFL
Openfda › UniiXB13HYU18U
Openfda › RouteNASAL
Openfda › Rxcui849506
Openfda › Spl idf90935bd-bb23-2f9c-3271-8508e92d45c4
Openfda › Brand nameDESMOPRESSIN ACETATE
Openfda › Spl set id1ac423b8-27a6-4cef-4a82-c50bf81b4f49
Openfda › Package ndc60505-0815-0
Openfda › Product ndc60505-0815
Openfda › Generic nameDESMOPRESSIN ACETATE
Openfda › Product typeHUMAN PRESCRIPTION DRUG
Openfda › Substance nameDESMOPRESSIN ACETATE
Openfda › Manufacturer nameApotex Corp.
Openfda › Application numberANDA076703
Openfda › Is original packagertrue
Event id98736
Address 12400 N Commerce Pkwy Ste 400
Address 2N/A
Code infoLot #: VM4231, Exp 06/30/2027
Postal code33326-3253
Report date20260422
Product typeDrugs
Product quantityN/A
Reason for recallDefective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.
Voluntary mandatedVoluntary: Firm initiated
Recall initiation date20260408
Initial firm notificationE-Mail
Center classification date20260501

Overview

  • Recalling FirmApotex Corp.
  • StatusOngoing
  • Risk LevelClass II
  • DistributionU.S.A. Nationwide
Official Agency Alert